SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Vascular Surgery Referral — Ella Fitzgerald

PatientElla Fitzgerald
Date of birth1956-04-25
IdentifiersMRN HR-ML029-SYN; SSN (made up) 000-29-3640
Document date2026-05-11
AuthorOdessa Whitlow, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Claudication of both calves, worse on the right, in a 70-year-old touring singer with type 2 diabetes, coronary bypass surgery last year, and an ankle-brachial index of 0.62 right and 0.74 left. Please define the arterial disease, advise on exercise and antithrombotic therapy, and tell us whether and when revascularization should be considered, so that her limbs are protected before any tissue is lost. [S]

Urgency: Within two to three weeks, on the same day as her two-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Calf cramping after about one and a half blocks for about a year, now limiting her walks through airports and to the stage; no rest pain, wounds, or color change. Diabetes for many years with retinopathy; A1c 8.6% with low glucose readings after late shows, so glipizide was stopped today, glargine reduced to 24 units and moved to the morning, and empagliflozin started. Five-vessel coronary bypass surgery last year; no angina; on aspirin 81 mg, metoprolol succinate 25 mg, and atorvastatin, raised today from 40 to 80 mg for an LDL of 92 mg/dL. Never smoked. Examination: femoral pulses present; popliteal and foot pulses absent on the right and foot pulses faint on the left; calluses under the second metatarsal heads and hammer toes; protective sensation intact; no ulcer (IWGDF risk category 2). Ankle-brachial index 0.62 right and 0.74 left; toe-brachial index 0.46 and 0.55. Creatinine 0.92 mg/dL, eGFR 67, potassium 4.4 mmol/L; urine albumin-creatinine ratio 18 mg/g; hemoglobin 12.4 g/dL. Right macular edema; retina clinic appointment pending. She tours in the United States and overseas and wants to keep performing; she decides who is told about her health [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with breakfast and the evening mealOral route2016-03-01activeS
Glipizide 10 mg oral tablet, one tablet by mouth twice daily before mealsOne tablet by mouth twice daily before breakfast and the evening mealOral route2021-09-01 to 2026-05-11completedS
Insulin glargine 100 units/mL pen, 30 units under the skin at bedtime30 units at bedtimeSubcutaneous route2023-04-01 to 2026-05-11completedS
Insulin glargine 100 units/mL pen, 24 units under the skin each morning24 units each morning, at the same clock time on tour, with written time-zone adjustmentsSubcutaneous route2026-05-11activeS
Atorvastatin 40 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-06-02 to 2026-05-11completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-11activeS
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-06-02activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-06-02activeS
Empagliflozin 10 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning; hold on days she cannot eat or drink normally and before surgeryOral route2026-05-11activeS
Glucagon 3 mg nasal powder, one spray into one nostril for a severe low glucoseOne spray into one nostril if she cannot safely swallow during a low glucose; may repeat once after 15 minutes with a new device; call 911Nasal route2026-05-11activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes mellitus with peripheral artery disease: cramping in both calves after about one and a half blocks of walking, worse on the right, easing within minutes of rest; no rest pain, wounds, or color change. Resting ankle-brachial index 0.62 right and 0.74 left, toe-brachial index 0.46 and 0.55; dorsalis pedis and posterior tibial pulses absent on the right and faint on the left. A1c 8.6% on metformin, glipizide and glargine, with low glucose readings (to 52 mg/dL) after late performances. Foot: protective sensation intact to the 10-g monofilament at all sites and to vibration; callus under the second metatarsal heads; hammer toes of the second and third toes; no ulcer (IWGDF risk category 2). Synthetic modern episode linked to her documented diabetes and its circulatory complicationsactiveconfirmed E11.51S — Synthetic modern diagnosis; the type of diabetes was not made public and is synthetic.
Moderate nonproliferative diabetic retinopathy with center-involving diabetic macular edema in the right eye (best-corrected acuity 64 letters, about 20/50) and moderate nonproliferative retinopathy without macular edema in the left eye (81 letters); lens implants in both eyes from earlier cataract surgery. Synthetic modern episode linked to her documented diabetic eye problemsactiveconfirmed E11.3311S — Synthetic modern eye diagnosis on retinal imaging and optical coherence tomography in the clinic; the left eye is described in the display.
Coronary artery disease after five-vessel coronary bypass surgery last year, with an intensive care stay; no angina now; on aspirin, a statin, and metoprolol. Synthetic modern episode linked to her documented heart surgeryactiveconfirmed I25.10S — Synthetic modern coding of her documented heart surgery; bypass grafts are described in the display.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1970sDiabetes affecting her eyes, with health problems beginning in the 1970sD (CLM-0007)
1970sCataract surgery, after which she returned to touring more than 40 weeks a yearD (CLM-0008)
1986Intensive care admission for heart trouble and quintuple-bypass heart surgeryD (CLM-0009)

Family History

RelativeConditionAge at deathEvidence
motherDied suddenly of a heart attack in 1932; age at death not recorded in the cited sourceD (CLM-0002)

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-11Body height165cmS
2026-05-11Body weight84kgS
2026-05-11Body mass index (BMI) [Ratio]30.9kg/m2S
2026-05-11Systolic blood pressure126mm[Hg]S
2026-05-11Diastolic blood pressure70mm[Hg]S
2026-05-11Heart rate62/minS
2026-05-11Respiratory rate16/minS
2026-05-11Body temperature36.6CelS
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-11Hemoglobin A1c/Hemoglobin.total in Blood8.6%Below 5.7% is normal; her individualized goal is below 7.5%HighS
2026-05-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-05-11Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-05-11Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
2026-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-11Glucose [Mass/volume] in Serum or Plasma168mg/dL70-99 mg/dLHighS
2026-05-11Albumin/Creatinine [Mass Ratio] in Urine18mg/g<=30 mg/gNormalS
2026-05-11Cholesterol [Mass/volume] in Serum or Plasma164mg/dL<=199 mg/dLNormalS
2026-05-11Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation92mg/dLHer goal with coronary and peripheral artery disease is below 55 mg/dLNormalS
2026-05-11Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=50 mg/dLLowS
2026-05-11Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
2026-05-11Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-35 U/LNormalS
2026-05-11Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L10-35 U/LNormalS
2026-05-11Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
2026-05-11Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma386pg/mL232-1245 pg/mLNormalS
2026-05-11Ankle-brachial index0.62{ratio}1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormalLowS
2026-05-11Ankle-brachial index0.74{ratio}1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormalLowS
2026-05-11Toe brachial index - right0.46{ratio}Above 0.70 normalLowS
2026-05-11Toe brachial index - left0.55{ratio}Above 0.70 normalLowS
2026-05-11Visual acuity best corrected Right eye by ETDRS eye chart64{letters}85 letters is about 20/20; 80 about 20/25; 65 about 20/50LowS
2026-05-11Visual acuity best corrected Left eye by ETDRS eye chart81{letters}85 letters is about 20/20; 80 about 20/25; 65 about 20/50NormalS

Assessment

Plan of Treatment